Trial intelligence / Profile preview

Triamcinolone injection vs no injection for forearm edema after loop forearm arteriovenous graft

TCTR20230405005Phase 3Unknown

Sponsor
Ramathibodi Hospital
Start
Apr 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of triamcinolone acetonide in end-stage kidney disease (ESKD), sponsored by Ramathibodi Hospital. Status: unknown.

02

Drugs

triamcinolone acetonide
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on TCTR20230405005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230405005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call